Product description

The objective is to develop Duloxetine DR pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents
Read more

Specifications

Categories APIsOther APIs
Sales markets Eastern Europe; Asia; Central/South America
Supplied from India

More products from Murli Krishna Pharma

View all our products (30)

Products from other suppliers

Duloxetine

Contact information

Address

Telephone

Website

View all contact information